Val-CDCA is a chenodeoxycholate (CDCA) and C-24 L-Valine (HY-N0717) conjugate. Val-CDCA inhibits taurocholate uptake in human NTCP-stably transfected HEK293 cells. Val-CDCA can be used for HBV infection[1].
Molecular Weight:
491.70
CAS Number:
[1640013-00-8]
Formula:
C29H49NO5
Target:
Drug Derivative,HBV
Application Notes:
MCE Product type: Natural Products
* VAT and and shipping costs not included. Errors and price changes excepted